Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:57:21.268Z.
Calculation as of: 2026-10-06T15:57:21.268Z.
Quote observation: 2026-10-06T15:47:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ceb9d7bb150905ac81611c4688aa1bd793b2f4eb464ba4dc05e218b0340a6d90
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$1.50M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewcelX Ltd. (NCEL) | $1.39M | N/A | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.39M | N/A | N/A | N/A | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.40M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.37M | N/A | N/A | N/A | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | N/A | 8.14 | 8.14 | 8.14 |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | N/A | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.48M | N/A | 58.11 | 58.11 | 58.11 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | N/A | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.16M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.14M | N/A | 3.00 | 2.75 | 2.75 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
